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Abstract
Because of their outstanding physical properties, carbon nanotubes (CNTs) are promising new materials in the field of nanotechnology. It
is therefore imperative to assess their adverse effects on human health. Monocytes/macrophages that recognize and eliminate the inert
particles constitute the main target of CNTs. In this article, we report our finding that double-walled CNTs (DWCNTs) synergize with Toll-
like receptor agonists to enhance IL-1β release in human monocytes. We show that DWCNTs–induced IL-1β secretion is exclusively linked
to caspase-1 and to Nlrp3 inflammasome activation in human monocytes. We also establish that this activation requires DWCNTs
phagocytosis and potassium efflux, but not reactive oxygen specied (ROS) generation. Moreover, inhibition of lysosomal acidification or
cathepsin-B activation reduces DWCNT-induced IL-1β secretion, suggesting that Nlrp3 inflammasome activation occurs via lysosomal
destabilization. Thus, DWCNTs present a health hazard due to their capacity to activate Nlrp3 inflammasome, recalling the inflammation
caused by asbestos and hence demonstrating that they should be used with caution.
From the Clinical Editor: This is a very important biosafety/toxicity study regarding double walled carbon nanotubes. The investigators
demonstrate that such nanotubes do represent a health hazard due to their capacity to activate Nlrp3 inflammasome, resembling the
inflammation caused by asbestos. While further study of this phenomenon is definitely needed, the above findings clearly suggest that special
precautions need to be taken when applying these nanoparticles in human disease research.
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With the increasing use of carbon nanotubes (CNTs), public
concern about their potential risk to human health has also
risen.1-3 CNTs offer many useful properties, due to their large
surface area in comparison with larger particles. They are used
for many different purposes, including microelectronics and
surface coating. We distinguish three types of CNTs with their
own physical and chemical properties: single-walled CNTs
(SWCNTs), double-walled CNTs (DWCNTs), and multiwalled
CNTs (MWCNTs). DWCNTs (Figure 1, A) are the simplest
member of the MWCNTs.3-5 This structure offers several
advantages. In particular, the outer wall can be functionalized
(even covalently) to enhance dispersion or bring new function-
alities while retaining the remarkable mechanical and electronic
properties of the inner nanotube.6
Recent works highlighted that CNTs induced a strong acute
inflammatory reaction through the secretion of pro-inflammatory
cytokines in mice treated with SWCNTs.3 Indeed, mice
intranasally instilled with DWCNTs showed an increase in
interleukin (IL)-6 (IL-6) plasma levels.4 Consistent with these
data, Inoue et al showed that the intratracheal exposure of mice
with SWCNTs and MWCNTs promoted secretion of the pro-
inflammatory interleukin-1β (IL-1β) through their peripheral blood
monocytes.5 Although the in vivo pro-inflammatory potential of
CNTs has been suggested, the signaling pathways leading to the
increase in the pro-inflammatory cytokine IL-1β secretion in
human monocytes/macrophages has not yet been determined.
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Inflammatory cytokines of the IL-1 family, such as IL-1α,
IL-1β, and IL-18 are potent mediators of innate immunity.7,8
These cytokines are regulated both on transcriptional and post-
transcriptional levels. Their production requires two steps: a
priming event triggering the transcription of pro-cytokines, such
as IL-1β; the proteolytic processing of proIL-1β by caspase-1 to
generate the “mature” IL-1β and the release of mature IL-1β from
cells.9 Processing of pro-IL-1β requires assembly and activation
of inflammasomes, which are cytoplasmic multiprotein com-
plexes that contain Nod-like receptor (NLR) and caspase-1
proteins.10 The Nlrp3 inflammasome consists of three main
components: the NLR-family protein, Nlrp3, procaspase-1, and
the ASC (apoptosis speck-like protein containing a CARD)
adapter, which link Nlrp3 to ASC. Following auto-activation
through inflammasome assembly, caspase-1 cleaves IL-1β,
whose biologically active form is then secreted. Consequently,
the production of IL-1β implies two separate signals to yield the
active pro-inflammatory cytokine. First, the stimulation of
pattern recognition receptors, such as Toll-like Receptors
(TLRs) and cytokine receptors, is required for synthesis of
pro-IL-1β protein in cells. Then, a second signal is needed for
Nlrp3 inflammasome activation responsible for proIL-1β
cleavage and IL-1β secretion.7,8 Thus, the signal activating the
inflammasome is necessary and sufficient when the cells are
naturally primed by environmental antigens. Conversely, the
activation of pattern-recognition receptors that control IL-1
family cytokine transcription is necessary but not sufficient.
Recently, the activation of the Nlrp3 inflammasome by toxins,
ATP, silica, asbestos, SiO2 and TiO2 nanoparticles (NPs) has
been characterized in vitro in monocytes, macrophages, and
dendritic cells11-13 primed with TLR ligands, such as lipopoly-
saccharides (LPS), peptidoglycans (PGN) or synthetic triacy-
lated lipoprotein (PAM3CSK4). In the study reported here, we
investigated the effect of DWCNTs on pro-inflammatory IL-1
family release of human monocytes through inflammasome
activation using an in vitro experimental model of LPS-primed
human monocytes. We showed that DWCNTs induced the
proteolytic processing of pro-IL-1β through Nlrp3 inflamma-
some activation in human monocytes. This activation required
DWCNTs actin cytoskeletal filament rearrangement, potassium
efflux, and lysosomal destabilization.
Methods
Cell preparation
Primary Human Monocytes (PHMs) were obtained from
healthy donors (Etablissement Français du Sang, Toulouse,
France) and purified using the Ficoll-Hypaque method as
previously described.14 Written informed consent was obtained
from the donors under EFS Contract n°21/PVNT/TOU/UPS04/
2010-0025. Following articles L1243-4 and R1243-61 of the
French Public Health Code, the contract was approved by the
French Ministry of Sciences and Technology (Agreement n°AC
2009-921). Rapidly, peripheral bone marrow (PBM) cells
were isolated from blood of healthy donors in accordance with
EFS on Ficoll gradient and were seeded in plate for 2 hours.
Cells were washed three times in phosphate-buffered saline
Figure 1. DWCNTs induce IL-1β and IL-18 but not TNFα and IL-6 secretion in LPS-primed human monocytes. (A) Scanning electronic microscopy (1) and
TEM (2) images of bulk DWCNTs before dispersion. (B-E) IL-1β, IL-18, TNFα and IL-6 release in culture supernatant of untreated or LPS-primed human
monocytes stimulated with raw DWCNTs, oxidized DWCNTs, ATP, or CB. (F) IL-1βmRNA level in untreated or LPS-primed human monocytes stimulated or
not with DWCNTs or CB. *P ≤ 0.05, **P ≤ 0.01 in comparison with the LPS-primed human monocytes.§P ≤ 0.05,§§P ≤ 0.01 in comparison with the
respective unprimed human monocytes. Data are means ± SEM. The data are representative of three independent experiments.
(PBS) (without calcium or magnesium) and adherent cells were
used for experiments in synthetic freshwater medium (SFM)
culture provided by Invitrogen (Gibco, Saint Aubin, France).
DWCNT preparation
Raw DWCNTs were synthesized by Catalytic Chemical
Vapor Deposition (CCVD) as described earlier.15 DWCNTs
were produced by CCVD decomposition of CH4 over Mg1
−xCoxO solid solution containing a small addition of molybde-
num. High-resolution transmission electron microscopy (TEM)
showed that a typical sample consists of approximately 80%
DWCNTs, 15% SWCNTs, and 5% TWCNTs. The Brunauer
Emmett Teller (BET) specific surface area was 985 m2.g-1.The
diameter distribution of the DWCNTs ranged from 0.5 to 2.5 nm
for inner tubes and from 1.2 to 3.2 nm for outer tubes. The length
of individual DWCNTs usually ranged between 0.1 and 100 μm
(in bundles). For some experiments, oxidized DWCNTs were
used. The raw DWCNTs were heated in 3 M HNO3 for 24 hours
in reflux conditions at 130°C. They were then washed with
deionized water on a polypropylene filtration membrane
(0.45 μm pore size) until neutrality, before being freeze-dried.
A typical sample presented 0.3 wt % of Cobalt and 150 ppm of
Mo after reflux treatment (Figure S1). Then, a hexane and water
extraction procedure was used to separate the water-soluble and
insoluble DWCNTs.16
DWCNTswere sonicated in culture medium for 5minutes and
then rapidly centrifuged. The supernatant containing DWCNTs
was homogenized and immediately used for experiments.
Stimulation assay
To evaluate IL-1β secretion and caspase-1 activation, human
monocytes were primed with ultrapure LPS (2 ng.mL-1) (Invivo-
gen, Toulouse, France), with peptidoglycan (0.5 ng.mL -1)
purchased from Sigma-Aldrich (Saint Quentin, France) or PAM3-
CSK4 (5 ng.mL
-1) (Sigma-Aldrich) for 8 hours. Then, PHMs were
stimulated with DWCNTs (25 μg.mL-1) or carbon black (CB) (25
μg.mL-1) (Degussa, Dusseldorf, Germany) for 18 hours or with
ATP (2 mM) (Sigma-Aldrich) for 4 hours. In some experiments,
cells were pre-incubated with cathepsin inhibitor (CA-074, 25
μM), cathepsin-B inhibitor (CA-074Me, 25 μM), bafilomycin A1
(125 nM) provided by Calbiochem (Merck, Lyon, France), cas-
pase inhibitor (z-vad, 40 μM), caspase-1 inhibitor (z-yvad, 50
μM), caspase-3 inhibitor (z-devd, 50 μM) obtained from
Biovision (Clinisciences) or latrunculin A (Sigma-Aldrich) (2
mM), 1 hour before DWCNTs, CB, or ATP stimulation.
Cytokine measurement
For cytokine detection, ELISA kits for IL-1β, TNF-α, IL-6
(Becton Dickinson, Grenoble, France) and IL-18 (R & D
Systems, Lille, France) human cytokines were used. They were
used according to the manufacturers' instructions.
Reverse transcription and real-time PCR
Adherent PHMs were incubated with 25 μg. mL-1 of
DWCNTs or CB for 5 hours. The cells were then lysed in
RLT buffer supplemented with 1% β-Mercapto-ethanol and
mRNAs were obtained with RNeasy Mini Kit columns (Qiagen,
Courtaboeuf, France) using the manufacturer's protocol. Reverse
transcription of cDNA was performed according to the
manufacturer's recommendations (Thermo Electron, Saint
Herblain, France). Quantitative real-time PCR was performed
on a LightCycler system (Roche Diagnostics, Meylan, France)
using LightCycler 480 SYBR Green I Master (Roche Di-
agnostics). Ten microliters of reaction mixture were incubated;
the amplifications were performed for 50 cycles (10 seconds at
95°C, 10 seconds at 60°C, and 10 seconds at 72°C). The primers
(at a final concentration of 2 μM) were designed with the
software Primer 3 and listed below. β-actin mRNA was used as




CAG-CCA-ATC-TTC-ATT-GCT-CA-3′, β-actin; (Sense) 5′-
CCT-CAC-CCT-GAA-GTA-CCC-CA-3′, (Antisense) 5′-TGC-
CAG-ATT-TTC-TCC-ATG-TCG-3′. The results of qRT-PCR
data were analyzed as described previously.17
Western blot
Western blots were performed as previously described.18
Rabbit anti-caspase-1 antibody (Clinisciences, Nanterre, France)
was used at 1/400 and goat anti-actin at 1/800 (Clinisciences).
siRNA assay
Human Nlrp3 and control siRNA were purchased from Santa
Cruz Biotechnologies. PHMs were primed with LPS for 18 hours
and then incubated both with 100 nM of control siRNA or Nlrp3
siRNA and with Lipofectamine 2000 (Invitrogen) for 8 hours
according to the manufacturer's instructions. Then, transfection
medium was removed. Cells were then stimulated with DWCNTs
(50 μg. mL-1) and supernatant was used to determine IL-1β
protein level. Cell lysate was used to evaluate IL-1β mRNA level.
Potassium efflux inhibition
For potassium efflux inhibition, PHMs were primed with LPS
for 18 hours and then medium was replaced by serum-free buffer
containing 150 mM KCl, 5 mM NaH2PO4, 1 mM MgCl2, 1 mM
CaCl2, 10 mM HEPES and 1% BSA, pH 7.4. For control
experiment, a buffer containing 150 mM NaCl was used (150
mM NaCl, 5 mM KH2PO4, 1 mM MgCl2, 1 mM CaCl2, 10 mM
HEPES, 1% BSA, pH 7.4). Cells were then stimulated with
DWCNTs for 6 hours.
ROS
The oxygen-dependent respiratory burst of PHMs was
measured by chemiluminescence in the presence of 5-amino-2,3-
dihydro-1,4-phthalazinedione (66 μM, luminal; Sigma-Aldrich)
using a thermostatically (37°C) controlled luminometer (Wallac
1420 Victor2). The luminol detects both reactive oxygen and
nitrogen intermediates (O2
.-, ONOO-, OH.). The generation of
chemiluminescence was monitored continuously for 1 hour after
12-O-tetradecanoyl-phorbol-13-acetate (TPA, 100 μM; Sigma-
Aldrich) or DWCNT challenge. Statistical analysis was performed
using the area under the curve expressed in counts × seconds.
TEM
Cells exposed for 2 hours to 50 μg.mL-1 of DWCNTs were
analyzed by TEM. Cells were adherent on their plastic surface
and fixed in situ with a mix of 2% paraformaldehyde – 0.5%
glutaraldehyde, post-fixed in 1% osmic acid and embedded in
Epon. Fine (1-μm thick) and ultrafine (60-nm thick) slices were
cut, stained with uranyl acetate and lead salt, and observed under
Jeol 1010 TEM (60 keV).
Statistical analysis
For each experiment, the data were subjected to one-way
analysis of variance followed by the means multiple comparison
method of Bonferroni-Dunnet. P b 0.05 was considered as the
level of statistical significance.
Results
DWCNTs induce IL-1β and IL-18, but not TNFα or IL-6
secretion in LPS-primed PHMs
To determine the inflammatory potential of DWCNTs on
PHMs, the protein levels of IL-1β and IL-18, which belong to the
IL-1 family, were evaluated (Figure 1, B and C). Although
DWCNTs did not induce IL-1β and IL-18 secretion in unprimed-
PHMs, the treatment of LPS-primed PHMs with DWCNTs
resulted in a strong increase of IL-1β and IL-18 release. In
addition, the inert carbon black did not induce IL-1β and IL-18
secretion (Figure 1, B and C). Altogether these data demonstrate
that DWCNT-induced IL-1β release is not due to a nonspecific
effect of any carbon-based molecules on the PHMs. It is
interesting to note that the treatment of LPS-primed PHMs with
soluble-water oxidized DWCNTs did not alter the IL-1β release,
thus suggesting that their hydrophobic properties are not
involved in the DWCNT-induced IL-1β secretion (Figure 1, D).
In LPS-primed PHMs, the secretion of mature IL-1β and IL-
18 induced by DWCNTs was comparable with the amount
observed with ATP, known to be a potent activator of IL-1β
processing (Figure 1, B and C)19 These data demonstrate that
DWCNTs synergize with the TLR4 agonist to enhance IL-1β and
IL-18 release.
An interesting finding is that the treatment of LPS-primed
PHMs with DWCNTs did not increase the TNFα or IL-6
secretion in comparison with monocytes treated with LPS alone
(Figure 1, E). The IL-1β and IL-18 assays demonstrate that
DWCNTs act specifically on the processing of IL-1 family
cytokines independently of other pro-inflammatory cytokine-
production signaling pathways.
To determine whether DWCNTs induced IL-1β maturation
independently of its transcription, we evaluated IL-1β mRNA
level in PHMs. No difference was detected between LPS and
LPS-associated DWCNT conditions, showing that DWCNTs did
not induce IL-1β gene transcription (Figure 1, F).
In addition, we also evaluated DWCNT-induced-IL1β
secretion in PHMs differentiated into macrophages by M-CSF.
We demonstrate that DWCNTs also induced IL-1β secretion in
LPS-primed human macrophages (Figure S2). All together, these
results demonstrated that DWCNTs triggered the processing of
pro-IL-1β both in human monocytes and macrophages.
DWCNT–induced IL-1β release in human monocytes results
from Nlrp3-dependent caspase-1 activation
Caspase-1 is a key protease activated by the Nlrp3 inflamma-
some complex involved in the maturation of IL-1β protein. To
determine unequivocally whether caspase-1 is involved in the
DWCNT-induced IL-1β secretion by LPS-primed PHMs, we
evaluated IL-1β secretion in the presence of specific caspase
inhibitors. The use of z-vad, an inhibitor of proteases that belongs
to the caspase family, revealed that IL-1β secretion by PHMs after
DWCNT challenge was dependent on caspase activation because
the z-vad inhibits DWCNT-induced IL-1β secretion by LPS-
primed PHMs (Figure 2, A). Moreover, the treatment of PHMs
with the specific caspase-1 inhibitor z-yvad significantly decreased
DWCNT-induced IL-1β secretion, whereas the specific caspase-3
inhibitor z-devd did not change this secretion (Figure 2, B). This
data showed that the IL-1β secretion induced by DWCNTs was
exclusively linked to caspase-1 activation (Figure 2, B).
Caspase-1 activation involves autocatalytic processing of the
45 kDa pro-caspase-1 to generate two subunits, p20 and p10.8,20
To further explore whether caspase-1 was activated in DWCNT-
stimulated LPS-primed PHMs, we determined the appearance of
the p20 cleavage product by western blot (Figure 2, C). We
observed an increased p20 subunit level in response to
DWCNTs, which is significantly decreased in the presence of
caspase-1 inhibitor, confirming that DWCNT-mediated caspase-
1 activation to secrete IL-1β (Figure 2, C). Collectively, these
data suggest involvement of the Nlrp3 inflammasome in the
DWCNT-induced IL-1β response.
As Nlrp3 is involved in a specific caspase-1 activation
pathway for the processing of pro-inflammatory cytokines by
particles, the expression of Nlrp3 receptor was silenced in PHMs
using Nlrp3 siRNA (Figure 2, D). Figure 2, E shows that the
siRNA-mediated knockdown of Nlrp3 decreased IL-1β secretion
in PHMs treated with DWCNTs. Thus, we demonstrate here for
the first time the role of Nlrp3 receptor as the DWCNT responsive
mediator of inflammasome assembly in human monocytes.
We next analyzed the requirement of TLR signalling for Nlrp3
inflammasome activation by DWCNTs (Figure 2, F and G). To
determine whether DWCNT-induced IL-1β secretion was specif-
ically TLR4 dependent or not, DWCNTs were associated with
peptidoglycan, a TLR2 ligand, or with PAM3CSK4, a TLR1/2
activator21 (Figure 2, F and G). Importantly, the ability of
DWCNTs to promote IL-1β and IL-18 secretion was not limited to
LPS, as these NPs also significantly enhanced IL-1β and IL-18
secretion in response to a range of TLR agonists (Figure 2, F and
G). These data demonstrated that IL-1β secretion in response to
DWCNT treatment requires a first signal dependent on TLRs.
DWCNTs–induced IL-1β release in human monocytes requires
a potassium efflux, phagocytosis, and lysosomal acidification,
but not ROS production
Despite the identification and characterization of numerous
sterile and microbial activators of the Nlrp3 inflammasome, the
precise mechanism mediating inflammasome activation remains
unclear.8,22-25 Several pathways leading to its activation have been
described, such as efflux of cellular potassium, cathepsin B and
vacuolar acidification, and/or the generation of ROS.7,8,13,20,22 To
characterize the precise mechanism mediating inflammasome
activation by DWCNTs, we evaluated the involvement of the
potassium efflux and the phagocytosis process. Preventing the
potassium efflux by increasing extracellular potassium abolished
DWCNT-induced IL-1β secretion (Figure 3, A). Moreover, p20
subunit level strongly decreased in the presence of high
concentrations of potassium, establishing that caspase-1 cleavage
induced by DWCNTs was dependent on potassium efflux (Figure
3, B). In addition, the disruption of actin-mediated phagocytosis by
Latrunculin A suppressed DWCNT-induced IL-1β secretion in
PHMs (Figure 3, C), indicating that DWCNT phagocytosis was
required for inflammasome activation. Moreover, using TEM, we
demonstrated that some DWCNTs were located in phagosomes,
strongly suggesting that PHMs were able to phagocytose these
particles (Figure 3, D). These results suggest that the phagocytosis
of DWCNTs is required for inflammasome activation.
ROS are potent activators of the Nlrp3 inflammasome. We
investigated whether DWCNT phagocytosis was linked to Nlrp3
inflammasome-dependent ROS activation. Although PHMs
produced ROS in response to TPA, we demonstrated that
DWCNTs did not induce ROS production (Figure 4, A).
Moreover, the use of Trolox, a chemical ROS scavenger, did
not suppress DWCNT-induced IL-1β secretion (Figure 4, B).
Figure 2. DWCNT–induced IL-1β release in human monocytes results from Nlrp3-dependent caspase-1 activation. (A,B) IL-1β release in culture supernatant
of untreated or LPS-primed human monocytes stimulated with DWCNTs or CB in the presence of z-vad caspase inhibitor, z-yvad caspase-1 inhibitor or
z-devd-FMK caspase-3 inhibitor. *P ≤ 0.05, **P ≤ 0.01 in comparison with the LPS-primed human monocytes. §P ≤ 0.05, §§P ≤ 0.01 in comparison with
the respective unprimed human monocytes. ##P ≤ 0.01 in comparison with LPS-primed human monocytes stimulated with DWCNTs or CB. (C)
Representative immunoblot of mature p20 form and p45 pro-form respectively in supernatant and lysate of LPS-primed human monocytes stimulated or not
with DWCNTs in presence or not of z-yvad. (D) Nlrp3 mRNA level in LPS-primed human monocytes transfected with either a control siRNA or a Nlrp3
siRNA and stimulated or not with DWCNTs. *P ≤ 0.05 compared to human monocytes transfected with control siRNA. (E) IL-1β release in culture
supernatant of LPS-primed human monocytes transfected with either a control siRNA or a Nlrp3 siRNA stimulated or not with DWCNTs. **P ≤ 0.01
compared to human monocytes transfected with control siRNA. §§P ≤ 0.01 compared to human monocytes transfected with control siRNA and stimulated
with DWCNTs. (F) IL-1β and IL18 release in culture supernatant of untreated or peptidoglycan (PGN) TLR2 activator-primed human monocytes
stimulated with DWCNTs or CB. (G) IL-1β and IL18 release in culture supernatant of untreated or PAM3CSK4 TLR1/2 activator-primed human
monocytes stimulated with DWCNTs or CB. *P ≤ 0.05, **P ≤ 0.01 compared to the PGN- or PAM3CSK4-primed human monocytes.
§P ≤ 0.05, §§P ≤
0.01 compared to the respective unprimed human monocytes. Data are means ± SEM. The data are representative of three independent experiments.
Together, these data show that ROS production did not play a
key role in the mechanism by which phagocytosis is coupled to
DWCNT-induced inflammasome activation.
It has been proposed that Nlrp3 inflammasome may be
activated by lysosomal damage and the subsequent release of
cathepsin-B into the cytoplasm of cells.24,26 Inhibition of the
activation of all cathepsins by nonspecific inhibitor significantly
reduced DWCNT-induced IL-1β secretion (Figure 4, C). it is
interesting to note that the use of specific cathepsin-B inhibitor
highlighted cathepsin-B as the main protease involved in IL-1β
release by PHMs in response to DWCNTs (Figure 4, C). In
addition, treating PHMs with Bafylomycin A1, an inhibitor of
the H+ ATPase system required for lysosomal acidification,
significantly reduced the IL-1β response induced by DWCNTs
(Figure 4, D). All together, these data suggest that DWCNT
treatment of PHMs resulted in intracellular changes, including
lysosomal acidification. The release of cathepsin-B lysosomal
product into the cytosol may promote the generation of Nlrp3
inflammasome activation signals.
Discussion
Carbon nanotubes have a wide range of applications in
various sectors and their use is foreseen to increase in the future.
Thus, public concern about their adverse effects on human health
has also risen. Recent studies clearly demonstrated that CNTs
induce a strong pro-inflammatory reaction through the secretion
of IL-1β and IL-6 cytokines in mice exposed to these particles.4,5
Brown et al showed that MWCNTs induced a strong secretion of
IL-1β only in PMA-primed THP1 monocytic cell line.27
Although the pro-inflammatory potential of CNTs has been
suggested, the signaling pathways leading to the increase of pro-
inflammatory cytokine secretion remain unknown.
In this study, we investigated the capacity of double-walled
CNTs (DWCNTs) to stimulate the release of pro-inflammatory
cytokines in PHMs. The cytokines of the IL-1 family (IL-1α,
IL-1β, IL-18) are particularly potent pro-inflammatory mediators
strongly involved in the development of autoimmune disorders,
such as silicosis or asbestosis.7,8,20 The particularity of these
cytokines is that their secretion involves a signaling pathway
distinct from that of TNFα and IL-6 inflammatory cytokines.7,20
Indeed, after induction of their mRNAs by pro-inflammatory
mediators (TLR ligands) TNFα and IL-6 proteins are directly
secreted, whereas the production of IL-1 family cytokines
involves a complex regulation that requires two different
signals.20 First, the induction of IL-1β mRNA through the
stimulation of pattern recognition receptors, such as TLRs, is
required for synthesis of pro–IL-1β protein in cells. Then, a
second stimulus is necessary for inflammasome activation
leading to caspase-1–dependent cleavage and release of the
biologically active and mature IL-1 family cytokines.20 Several
Figure 3. DWCNTs–induced IL-1β release in human monocytes requires potassium efflux and phagocytosis. (A) IL-1β release in culture supernatant of
untreated or LPS-primed human monocytes stimulated with DWCNTs or ATP in the presence of elevated KCl or NaCl concentrations. **P ≤ 0.01 in
comparison with to LPS-primed human monocytes in the presence of NaCl. §P≤ 0.05, §§P≤ 0.01 in comparison with LPS-primed human monocytes stimulated
with DWCNTs or ATP in the presence of NaCl. (B) Representative immunoblot of mature p20 form and p45 pro-form in lysate of LPS-primed human
monocytes stimulated with DWCNTs in the presence or not of elevated KCl or NaCl concentrations. (C) IL-1β release in culture supernatant of untreated or
LPS-primed human monocytes stimulated with DWCNTs or ATP in the presence of Latrunculin A. **P ≤ 0.01 in comparison with the LPS-primed human
monocytes. §§P ≤ 0.01 in comparison with the respective unprimed human monocytes. ##P ≤ 0.01 in comparison with to LPS-primed human monocytes
stimulated with DWCNTs or ATP. (D) Representative transmission electron microscopy image of primary human monocytes stimulated with DWCNTs. Data
are means ± SEM. The data are representative of three independent experiments.
particles (asbestos) and NPs (nanosilica) have been found to
specifically induce IL-1β secretion through the activation of
inflammasome post-transcriptional mechanisms.7,8 In this con-
text, we investigated the impact of DWCNTs on the different
steps of the production of IL-1β by PHMs. We demonstrate in
this study that DWCNTs induced a strong secretion of IL-1β and
IL-18 in LPS-primed PHMs but not in unprimed PHMs,
supporting the idea that TLR agonists are indispensable to
enhance DWCNT-induced IL-1β and IL-18 release. Consistently,
previous studies have shown that only PMA-primed THP1 cells
and LPS-primed murine monocytes secrete IL-1β when they are
challenged with MWCNTs.27 An interesting aspect is that we
established that DWCNTs induced only IL-1β and IL-18 release
in LPS-primed PHMs. Indeed, the treatment of LPS-primed
PHMs with DWCNTs did not amplify TNFα or IL-6 secretion.
These data corroborate the findings of previous studies
highlighting the ability of silica and asbestos to specifically
increase IL-1β and IL-18 secretion, but not TNFα or IL-6 in LPS-
primed macrophages.7,8 In this study, we also demonstrated that
DWCNTs did not induce IL-1βmRNA gene expression, but they
activated the protease caspase-1. This DWCNT-induced caspase-
1 activation promoted the maturation of IL-1β, strongly
suggesting involvement of the inflammasome in this process.
Although DWCNTs alone did not alter the IL-1βmRNA levels in
PHMs, these particles seem to activate an inflammasome-
dependent signaling pathway required for their secretion.
Among the numerous inflammasomes identified, the Nlrp3
inflammasome is the best characterized.20 Many particles, such
as silica and asbestos, have been shown to specifically trigger
activation of the Nlrp3 inflammasome, leading to caspase-1
activation-induced IL-1β and IL-18 secretion.7,8,20 In this
study, we show that the silencing of the Nlrp3 gene strongly
reduced DWCNT-induced IL-1β secretion, demonstrating that
theNlrp3 inflammasome sensesDWCNT-associated danger signals
and contributes to triggering IL-1β and IL-18 release in PHMs.
Activation of the Nlrp3 inflammasome is subject to several
events, such as the efflux of cellular potassium, the phagocytosis
of particles, the generation of ROS, cathepsin B activation and/or
Figure 4. DWCNT–induced IL-1β release in human monocytes requires lysosomal acidification but not ROS production. (A) ROS production in human
monocytes untreated (control) or treated with DWCNTs or TPA. DWCNTs–induced respiratory burst of human monocytes was measured by
chemioluminescence. Total chemioluminescence emission (area under the curve expressed in counts × seconds) was observed continuously for 60 minutes
in the presence or not of DWCNTs or TPA. **P ≤ 0.01 in comparison with untreated human monocytes (control). (B) IL-1β release in culture supernatant of
untreated or LPS-primed human monocytes stimulated with DWCNTs in the presence of the ROS scavenger Trolox. **P ≤ 0.01 in comparison with the
LPS-primed human monocytes. §§P≤ 0.01 in comparison with the respective unprimed human monocytes. (C) IL-1β release in culture supernatant of untreated
or LPS-primed human monocytes stimulated with DWCNTs or ATP in the presence of cathepsin inhibitor (CA-074) or cathepsin B inhibitor (CA-074Me).
**P ≤ 0.01 in comparison with the LPS-primed human monocytes. §P ≤ 0.05, §§P ≤ 0.01 in comparison with the respective unprimed human monocytes.
##P ≤ 0.01 in comparison with LPS-primed human monocytes stimulated with DWCNTs or ATP. (D) IL-1β release in culture supernatant of untreated or
LPS-primed human monocytes stimulated with DWCNTs or ATP in the presence of Bafilomicyn A1. *P ≤ 0.05, **P ≤ 0.01 in comparison with the LPS-
primed human monocytes. §P ≤ 0.05, §§P ≤ 0.01 in comparison with the respective unprimed human monocytes. ##P ≤ 0.01 in compared with LPS-primed
human monocytes stimulated with DWCNTs. (E) IL-1β mRNA level in untreated or LPS-primed human monocytes stimulated or not with DWCNTs in the
presence of Bafilomicyn A1 or CA-074Me. *P≤ 0.05, **P≤ 0.01 in comparison with the LPS-primed human monocytes. Data are means ± SEM. The data are
representative of three independent experiments.
the vacuolar acidification.7,8,13,20,22 The efflux of cellular
potassium appears to be a common step shared by various
activators of the Nlrp3 inflammasome.7,8,20,22 Thus, it has been
suggested that the inflammasome works as a sensor of cellular
membrane disruption characterized by a loss of intracellular
potassium.22 We showed that prevention of the potassium efflux
by increasing extracellular potassium abrogated caspase-1
activation and IL-1β secretion, revealing that DWCNT-induced
potassium efflux triggers Nlrp3 inflammasome activation. These
data demonstrate that DWCNT–induced potassium efflux was
necessary for Nlrp3 inflammasome activation, suggesting that
these particles may affect cell membrane integrity. Moreover, we
showed that some DWCNTs are located in vesicles, demon-
strating that some DWCNTs are completely phagocytosed.
However, due to their great length heterogeneity (0.1 to 100 μm)
and their high potential for aggregation, certain large particles
were not completely phagocytosed by monocytes. In these
conditions, Brown et al previously showed the existence of
frustrated phagocytosis of CNTs by mononuclear cells.28
Recently, it has also been demonstrated that large particles,
such as alum, asbestos, and silica can induce the so-called
frustrated phagocytosis at the surface of the cells, provoking the
formation of actin cytoskeletal filaments.8,20 In addition, the
pharmacological inhibition of actin cytoskeleton-dependent
phagocytosis with Latrunculin A inhibited DWCNT-induced
IL-1β secretion, suggesting that both phagocytosis and frustrated
phagocytosis are involved in Nlrp3 inflammasome activation by
DWCNTs. Dostert et al has previously shown that the inhibition
of cytoskeletal filament generation with cytochalasin D or
colchicine disrupts the ability of asbestos and silica particles
to trigger IL-1β secretion, demonstrating that the frustrated
phagocytosis is involved in the NLRP3 inflammasome
activation,8 and this is consistent with our findings. It has
recently been shown that there is an alternative route for particle
penetration into cells that allows the activation of the inflamma-
some. Indeed, the entry into macrophages and keratinocytes of
TiO2 NPs by passive diffusion induces inflammasome activation
independently of actin-cytoskeleton rearrangements.13,29,30 In
this study, we showed that cytoskeletal filament rearrangement is
essential in the activation of the inflammasome by DWCNTs.
The difference between CNTs and TiO2 could be attributed to
their physicochemical discrepancies. Indeed, the shorter length
of NPs of TiO2 may allow them to penetrate cells more easily by
diffusion.13,29,30 An interesting aspect is that although TiO2 and
nano-ZnO used the same route to enter the cells, nano-ZnO did
not activate the Nlrp3 inflammasome.13 In view of these
differences, we suggest that independently of the way in which
they penetrate cells, both the NP structure and its chemical
properties are essential to trigger Nlrp3 inflammasome activa-
tion. In this study, the modification of the physicochemical
structure of the DWCNT surface by oxidation with nitric acid did
not affect their ability to induce IL-1 β release by PHMs, thus
demonstrating that their hydrophobic properties are not involved
in the DWCNT-induced IL-1β secretion.
Recent reports have suggested that ROS produced during
phagocytosis may be an important signal for inflammasome
activation by several stimuli, such as asbestos, silica, and
peptidoglycan particles.7,8,31 Here, we demonstrated that ROS
production was not involved in Nlrp3 inflammasome activation
by DWCNTs. Consistent with our results, it has been described
that CNT-induced ROS production was length dependent in the
THP1 monocytic cell line.27 In their study, Brown et al
demonstrated that short CNTs failed to promote ROS production,
but they were able to stimulate IL-1β release in PMA-primed
THP1.27,30 In line with this, amorphous silica-NP–mediated
Nlrp3 inflammasome activation in murine dendritic cells was
triggered independently of ROS production,32 suggesting that
ROS are not indispensable for Nlrp3 activation by NPs.
Our data also indicated that both cathepsin B activity and
lysosomal acidification contributed to DWCNT-mediated acti-
vation of the Nlrp3 inflammasome. Indeed, although neither
cathepsin B or H+ATPase inhibitors altered the mRNA level of
pro IL-1β, DWCNT-induced IL-1β secretion was significantly
decreased by the presence of these two inhibitors. These data
strongly suggested that phagosomal maturation is involved in the
DWCNT-induced Nlrp3 inflammasome activation. Phagosomal
rupture and cathepsin B activation have previously been shown
to be important in Nlrp3 inflammasome activation by silica
crystals and aluminum.23 The release of lysosomal products,
such as cathepsin B, into the cytosol might promote the
generation of danger signals sensed by the Nlrp3 inflammasome,
resulting in inflammasome assembly.
We demonstrate here, for the first time, that DWCNTs induce
IL-1β and IL-18 pro-inflammatory cytokine secretion by PHMs.
Importantly, we identify the Nlrp3 inflammasome as the
DWCNT-responsive element in human monocytes. Moreover,
the potassium efflux and phagocytosis processes are key
molecular pathways involved in the DWCNT-induced Nlrp3
inflammasome activation (see Graphical Abstract). Given the
critical role of the Nlrp3 inflammasome in the development of
severe chronic inflammation and cancer formation7,8 and the
impact of the DWCNTs observed on its activation, future
decisions will be necessary to prevent the possible health hazards
that these particles may represent.
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